ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,574 | +334.5% | 73,998 | +581.2% | 0.00% | +100.0% |
| Q2 2023 | $53,989 | +11008.8% | 10,863 | -85.9% | 0.00% | -90.0% |
| Q4 2022 | $486 | -99.7% | 77,228 | +352.9% | 0.01% | +150.0% |
| Q3 2022 | $184,000 | -88.2% | 17,053 | -90.0% | 0.00% | -89.2% |
| Q1 2022 | $1,560,000 | +45.4% | 171,247 | +138.2% | 0.04% | +105.6% |
| Q4 2021 | $1,073,000 | -58.4% | 71,891 | -27.3% | 0.02% | -63.3% |
| Q2 2021 | $2,580,000 | +743.1% | 98,912 | +716.1% | 0.05% | +444.4% |
| Q4 2020 | $306,000 | -25.7% | 12,120 | +11.0% | 0.01% | -50.0% |
| Q3 2020 | $412,000 | -80.9% | 10,923 | -78.3% | 0.02% | -83.2% |
| Q2 2020 | $2,158,000 | – | 50,399 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |